March 31, 2026
Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...
Current immunotherapies have dramatically improved clinical outcomes, but more than half of metastatic melanoma patients have poor responses and primary resistance. With ti...
Brain metastases remain a leading cause of death in patients with metastatic melanoma. One of the most exciting advances in the treatment of CNS metastases was combined che...
Immunotherapy has been remarkably successful in the treatment of melanoma, but not all patients benefit from therapy and its effects is in most cases temporary, followed by...
Many cancer immunotherapy patients fail to respond or progress after initially experiencing tumor regression. More than 25% of melanomas carry activating mutations in the d...
Both helper CD4 T cells and killer CD8 T cells are known to be involved in immune responses to cancer. Helper CD4 T cells assist immune responses to cancer by enhancing the...
The overall survival of a subset of patients with melanoma drastically improved with a type of treatment called immunotherapy, which activates the body’s immune system to...
The treatment of melanoma with checkpoint inhibitor (CPI) therapy has produced rapid and substantial gains in survival, and as a result, the indications for its use have st...
BC Pilot – James W. Smithy, MD, MHS
SMR Christopher J. Marshall Award – Sydney Shaffer, MD, PhD
SMR Young Investigator Award – Benjamin Izar, MD, PhD
Melanoma is a lethal form of skin cancer because it has a high propensity to metastasize, especially to the brain (often causing death). Compounding this problem is the obs...
Description: For patients with melanoma, timely diagnosis and prompt treatment are important for optimal outcomes, but some groups of patients may face barriers to accessin...
Oct 27, 2026 ET
